No Detail Found!

Oral zinc supplementation in management of hepatic encephalopathy in patients with cirrhosis; A study conducted in developing country.

Author(s)
Riaz Hussain Awan Department of Gastroenterology, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Ameet Jesrani Radiology Radiology, Sindh Institute of Urology and Transplantation, Karachi, Pakistan
Latif Aziz Memon Gastroenterology, Liaquat National Hospital, Karachi, Pakistan
Seema Nayab Department of Radiology, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
Khadim Hussain Awan Urology, Baqai Hospital, Karachi, Pakistan
Faqeer Muhammad Awan CMC Hospital, Larkana, Pakistan
Abstract
Objective: To evaluate the effectiveness of oral zinc supplementation in cirrhotic patients with hepatic encephalopathy. Study Design: Retrospective Cohort study. Setting: Department of Gastroenterology, Liaquat University of Medical and Health Sciences, Jamshoro. Period: 15th February 2019 to 15th August 2019. Material & Methods: Adult patients of either gender suffering from hepatic cirrhosis and presenting with hepatic encephalopathy of any grade were included. Zinc acetate in a dose of 600 mg was given orally to the patients for two weeks duration. Standard lactulose treatment was also given alongside. Blood ammonia measurement was done at baseline and also after 2 weeks of treatment. Performance was assessed by utilization of number connection test (NCT) at week 1 and week 2 weeks post treatment. Results: Study included of 135 patients among which majority 95 (70.4%) of the patients were males. The mean age of the patients were 55.72 + 10.32 years. 40 (26.62%) patients were seen in Child Pugh class A, 65 (48.14%) were seen in Child Pugh class B and 30 (22.2%) were seen in Child Pugh class C. Serum ammonia levels were reduced in 110 (81.48%) patients and improved performance in NCT was seen in 90 (66.66%) patients. There was significant reduction of ammonia levels and significant improvement of NCT test in male patients (p value <0.05) and in Child Pugh class A and B patients (p value <0.05). Conclusion: In addition to standard therapy, inclusion of oral zinc acetate resulted in normalization of blood zinc and ammonia levels with improved performance in NCT and overall hepatic encephalopathy.
Publication Details
Page(s) 183-187
DOI DOI not available
Published Journal: Professional Medical Journal, Volume: 30, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
chronic liver disease, Hepatic encephalopathy, Hepatic Cirrhosis, Oral Zinc, Zinc Acetate.
0

Citations

0

Downloads

82

Views